These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22651910)

  • 1. Casting a shadow on liver X receptor-mediated atheroprotection: is LXRβ to blame?
    Degirolamo C; Moschetta A
    J Intern Med; 2012 Nov; 272(5):449-51. PubMed ID: 22651910
    [No Abstract]   [Full Text] [Related]  

  • 2. LXRβ activation increases intestinal cholesterol absorption, leading to an atherogenic lipoprotein profile.
    Hu X; Steffensen KR; Jiang ZY; Parini P; Gustafsson JÅ; Gåfvels M; Eggertsen G
    J Intern Med; 2012 Nov; 272(5):452-64. PubMed ID: 22329358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EP 80317, a CD36 selective ligand, promotes reverse cholesterol transport in apolipoprotein E-deficient mice.
    Bujold K; Mellal K; Zoccal KF; Rhainds D; Brissette L; Febbraio M; Marleau S; Ong H
    Atherosclerosis; 2013 Aug; 229(2):408-14. PubMed ID: 23880196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear receptors and cholesterol metabolism in the intestine.
    Moschetta A
    Atheroscler Suppl; 2015 Feb; 17():9-11. PubMed ID: 25659870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
    Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
    Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow angiotensin AT2 receptor deficiency aggravates atherosclerosis development by eliminating macrophage liver X receptor-mediated anti-atherogenic actions.
    Kato T; Kawahito H; Kishida S; Irie D; Wakana N; Kikai M; Takata H; Ogata T; Ueyama T; Matoba S; Yamada H
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):936-46. PubMed ID: 25487979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis.
    Hsieh J; Koseki M; Molusky MM; Yakushiji E; Ichi I; Westerterp M; Iqbal J; Chan RB; Abramowicz S; Tascau L; Takiguchi S; Yamashita S; Welch CL; Di Paolo G; Hussain MM; Lefkowitch JH; Rader DJ; Tall AR
    Nature; 2016 Jul; 535(7611):303-7. PubMed ID: 27383786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of macrophage overexpression of murine liver X receptor-alpha (LXR-alpha) on atherosclerosis in LDL-receptor deficient mice.
    Teupser D; Kretzschmar D; Tennert C; Burkhardt R; Wilfert W; Fengler D; Naumann R; Sippel AE; Thiery J
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2009-15. PubMed ID: 18787185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanism of curcumin on the suppression of cholesterol accumulation in macrophage foam cells and atherosclerosis.
    Zhao JF; Ching LC; Huang YC; Chen CY; Chiang AN; Kou YR; Shyue SK; Lee TS
    Mol Nutr Food Res; 2012 May; 56(5):691-701. PubMed ID: 22648616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism.
    Shin SK; Ha TY; McGregor RA; Choi MS
    Mol Nutr Food Res; 2011 Dec; 55(12):1829-40. PubMed ID: 22058071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excess nitric oxide impairs LXR(α)-ABCA1-dependent cholesterol efflux in macrophage foam cells.
    Zhao JF; Shyue SK; Lin SJ; Wei J; Lee TS
    J Cell Physiol; 2014 Jan; 229(1):117-25. PubMed ID: 23836449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice.
    Alberti S; Schuster G; Parini P; Feltkamp D; Diczfalusy U; Rudling M; Angelin B; Björkhem I; Pettersson S; Gustafsson JA
    J Clin Invest; 2001 Mar; 107(5):565-73. PubMed ID: 11238557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separate and overlapping metabolic functions of LXRalpha and LXRbeta in C57Bl/6 female mice.
    Korach-André M; Parini P; Larsson L; Arner A; Steffensen KR; Gustafsson JA
    Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E167-78. PubMed ID: 19690071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathologic and biochemical changes during disease progression in liver X receptor beta-/- mice, a model of adult neuron disease.
    Bigini P; Steffensen KR; Ferrario A; Diomede L; Ferrara G; Barbera S; Salzano S; Fumagalli E; Ghezzi P; Mennini T; Gustafsson JA
    J Neuropathol Exp Neurol; 2010 Jun; 69(6):593-605. PubMed ID: 20467332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent advances on liver X receptors].
    Wang Q; Jiang Y
    Sheng Li Ke Xue Jin Zhan; 2009 Apr; 40(2):147-50. PubMed ID: 19558144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute intake of plant stanol esters induces changes in lipid and lipoprotein metabolism-related gene expression in the liver and intestines of mice.
    De Smet E; Mensink RP; Konings M; Brufau G; Groen AK; Havinga R; Schonewille M; Kerksiek A; Lütjohann D; Plat J
    Lipids; 2015 Jun; 50(6):529-41. PubMed ID: 25931382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherosclerosis induced by arsenic in drinking water in rats through altering lipid metabolism.
    Cheng TJ; Chuu JJ; Chang CY; Tsai WC; Chen KJ; Guo HR
    Toxicol Appl Pharmacol; 2011 Oct; 256(2):146-53. PubMed ID: 21851829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17β-estradiol promotes cholesterol efflux from vascular smooth muscle cells through a liver X receptor α-dependent pathway.
    Wang H; Liu Y; Zhu L; Wang W; Wan Z; Chen F; Wu Y; Zhou J; Yuan Z
    Int J Mol Med; 2014 Mar; 33(3):550-8. PubMed ID: 24398697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute psychological stress accelerates reverse cholesterol transport via corticosterone-dependent inhibition of intestinal cholesterol absorption.
    Silvennoinen R; Escola-Gil JC; Julve J; Rotllan N; Llaverias G; Metso J; Valledor AF; He J; Yu L; Jauhiainen M; Blanco-Vaca F; Kovanen PT; Lee-Rueckert M
    Circ Res; 2012 Nov; 111(11):1459-69. PubMed ID: 22931956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo macrophage-specific RCT and antioxidant and antiinflammatory HDL activity measurements: New tools for predicting HDL atheroprotection.
    Escolà-Gil JC; Rotllan N; Julve J; Blanco-Vaca F
    Atherosclerosis; 2009 Oct; 206(2):321-7. PubMed ID: 19362310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.